Vetsys Pharmaceutical
Vetsys Pharmaceutical
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our state-of-the-art facility includes specialized workshops for producing powders, premixes, injections, oral solutions, and our core specialty: high-performance Intramammary Infusions.
We distinguish ourselves by placing a strong emphasis on technological development. Our independent research institute is equipped with five specialized laboratories and a team of world-class scientists, allowing us to adapt to market demands and produce cutting-edge solutions for global veterinary health.
Quality is the cornerstone of our operations. Vetsys adheres to rigorous GMP (Good Manufacturing Practices) standards. Every batch undergoes extensive quality control checks, ensuring we remain a reliable partner for international distributors and large-scale dairy farms.
The global market for Intramammary Infusions is witnessing a paradigm shift. As the dairy industry scales up in regions like Asia-Pacific, South America, and Eastern Europe, the prevalence of mastitis remains the most significant economic challenge for milk producers. Mastitis doesn't just affect animal welfare; it directly impacts milk yield, quality, and farm profitability. Consequently, the demand for high-efficacy treatments like Cefquinome Sulfate and Amoxicillin Sulbactam infusions is at an all-time high.
Our production lines integrate AI-driven precision and clean-room technologies.
International buyers, from government tenders to private veterinary hospitals, seek Intramammary Infusion Exporters who can offer stability in supply and competitive pricing. With the rising cost of raw materials in Europe and North America, sourcing from a top-tier Chinese factory like Vetsys provides a strategic cost advantage without compromising on ISO 9001 or GMP quality standards.
In different regions, the application varies:
• Intensive Dairy Farms (Middle East/Asia): Focused on rapid treatment of clinical mastitis in lactating cows to minimize milk discard time.
• Pasture-Based Systems (Oceania/South America): Higher demand for dry cow infusions to manage udder health across the non-lactating period.
Vetsys is not just a manufacturer; we are a strategic partner. Our advantages as a Chinese factory include:
As part of our long-term vision, Vetsys is committed to sustainability. We invest in green technologies and environmentally friendly manufacturing practices to minimize our carbon footprint. Our products are designed for efficacy while promoting the overall well-being of both animals and the environment. We are actively exploring international partnerships and research collaborations to bring high-quality, innovative animal health solutions to the global stage.
